TA-1801
Names
Biological Activity
[Description]:
TA-1801 is a hypolipidemic agent.
[Related Catalog]:
[In Vitro]
TA-1801 inhibits platelet aggregation in vitro[1].
[In Vivo]
TA-1801 reduces serum cholesterol and triglyceride levels by 23% and 35%, respectively, at a dose of 0.05% in a diet in normal rats, and it is about 10 times more active in hereditary hyperlipidemic rats (THLR/1) than in normal rats[1].
[References]
[Related Small Molecules]
Captisol
|
Cyclosporin A
|
H2DCFDA
|
0MPTP hydrochloride
|
GW4869
|
Etomoxir
|
TD139
|
Mitoquinone mesylate
|
GSK2795039
|
JC-1
|
BAPTA-AM
|
AP 20187
|
Setanaxib (GKT137831)
|
D-Luciferin
|
Crotaline
Chemical & Physical Properties
[ Density]:
1.275g/cm3
[ Boiling Point ]:
471ºC at 760 mmHg
[ Molecular Formula ]:
C17H14ClNO4
[ Molecular Weight ]:
331.75000
[ Flash Point ]:
238.6ºC
[ Exact Mass ]:
331.06100
[ PSA ]:
65.47000
[ LogP ]:
4.36060
[ Index of Refraction ]:
1.556
[ Storage condition ]:
2-8℃